TG and breast cancer: Notably, estrogen signaling, endocrine resistance, breast cancer, and thyroid hormone signaling emerged as the primary pathways, exhibiting signal values up to 6.0 and lower false discovery rates (FDRs) of 1.0 × 10−14.